Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 66.50
-1.00 (-1.48%)
Apr 1, 2026, 1:07 PM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 946.3 million as of April 1, 2026. Its market cap has decreased by -33.50% in one year.
Market Cap
946.30M
Enterprise Value
920.33M
Revenue
117.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.50
Market Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 946.30M, a decrease of -48.25%. That is a compound annual growth rate of -13.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 946.30M | -7.64% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | 1.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 237.54B |
| Caliway Biopharmaceuticals | 126.10B |
| Heron Neutron Medical | 61.90B |
| Bora Pharmaceuticals | 57.78B |
| Holy Stone Healthcare | 1.03B |
| Prince Pharmaceutical | 1.01B |
| Original BioMedicals | 1.01B |
| NatureWise Biotech & Medicals | 961.20M |